The pressing need to improve understanding of the mechanistic basis of transplant rejection and tolerance and to translate advances to the clinic, provides exciting opportunities for cutting-edge basic and translational scientists. There is a critical need for training programs that optimally prepare the next generation of transplantation researchers. With strong institutional support, the University of Pittsburgh School of Medicine (UPSOM) Starzl Transplantation Institute (STI) provides a unique academic environment, with an outstanding translational research base and culture, conducive to strong and comprehensive, broad-based training of young basic scientists and physicians in transplantation biology. Our established and proven Interdisciplinary Training Program in Transplantation Biology (TPTB) is very clearly delineated from other (successful) training programs at UPSOM. Our training program helps ensure that highly-trained investigators, strongly focused on transplantation, are available to assume leadership roles in academia, industry and government-affiliated research. Our highly-accomplished and well-funded participating faculty, further strengthened since our last renewal application by research leadership recruits, particularly in bone marrow and lung transplantation, have a very successful record of productive collaboration and strong commitment to training of young investigators. Expertise includes immunogenetics, ischemia-reperfusion injury, antigen-presenting cell, T and B cell biology, stem cell biology, tolerance induction, liver immunology, transplant infectious disease, chronic rejection, allo- and xenorecognition, xenotransplantation and human transplant immunology. A unique feature of our Training Program is that investigations range from those in invertebrates (a new trainer on the grant is expert in invertebrate allorecognition) and rodents to non-human primates and humans. Our trainees have been very successful publishing in leading journals, and in obtaining individual research fellowships, recognition and career development awards and faculty positions. Our goal is to produce outstanding, potentially independent investigators, highly conversant with fundamental and translational questions in transplantation biology and equipped with appropriate investigational, survival and career development skills. Pre-doctoral trainees are selected from graduate students enrolled in the Interdisciplinary Biomedical Graduate Training Program at UPSOM, including those in the medical scientist training program, who seek a PhD in transplantation biology. Based on successes achieved during the 2 previous funding periods of this Training Grant, the availability of well-qualified applicants and review of our original competing renewal application, we request support of 2 pre- doctoral trainees in year 11 and subsequent years. Postdoctoral trainees with MD, PhD, or dual degrees will be selected based on their outstanding potential and supported for 2 years. Support is requested for 2 postdoctoral trainees in year 11 and subsequent years. Our training faculty are strongly committed to ensuring appointments of members of underrepresented diversity groups to the grant.

Public Health Relevance

Training students and fellows in transplantation biology provides the next generation of scientists who will improve understanding of transplant rejection and acceptance, and develop treatments to reduce patients? dependence on immunosuppressive drugs. This training program teaches young scientists the necessary skills to develop research careers in transplantation with a strong emphasis on immunology and cell and molecular biology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI074490-12
Application #
9728825
Study Section
Allergy, Immunology, and Transplantation Research Committee (AITC)
Program Officer
Gondre-Lewis, Timothy A
Project Start
2007-09-01
Project End
2023-08-31
Budget Start
2019-09-01
Budget End
2020-08-31
Support Year
12
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Surgery
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Dai, Helong; Watson, Alicia R; Fantus, Daniel et al. (2018) Rictor deficiency in dendritic cells exacerbates acute kidney injury. Kidney Int 94:951-963
Sanders, Steven M; Ma, Zhiwei; Hughes, Julia M et al. (2018) CRISPR/Cas9-mediated gene knockin in the hydroid Hydractinia symbiolongicarpus. BMC Genomics 19:649
van der Windt, Dirk J; Sud, Vikas; Zhang, Hongji et al. (2018) The Effects of Physical Exercise on Fatty Liver Disease. Gene Expr 18:89-101
Ono, Yoshihiro; Perez-Gutierrez, Angelica; Nakao, Toshimasa et al. (2018) Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance. Hepatology 67:1499-1515
Varley, Patrick R; Tohme, Samer T; Chidi, Alexis P et al. (2018) Dissemination of Minimally Invasive Liver Resection for Primary Malignancy: Reevaluating Effectiveness. Ann Surg Oncol 25:808-817
Watson, Alicia R; Dai, Helong; Diaz-Perez, Julio A et al. (2018) mTORC2 deficiency in cutaneous dendritic cells potentiates CD8+ effector T cell responses and accelerates skin graft rejection. Am J Transplant :
van der Windt, Dirk J; Sud, Vikas; Zhang, Hongji et al. (2018) Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology 68:1347-1360
Ratay, Michelle L; Balmert, Stephen C; Bassin, Ethan J et al. (2018) Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease. Acta Biomater 71:261-270
Matta, B M; Reichenbach, D K; Blazar, B R et al. (2017) Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses. Am J Transplant 17:320-327
Fantus, Daniel; Dai, Helong; Ono, Yoshihiro et al. (2017) Influence of the Novel ATP-Competitive Dual mTORC1/2 Inhibitor AZD2014 on Immune Cell Populations and Heart Allograft Rejection. Transplantation 101:2830-2840

Showing the most recent 10 out of 91 publications